Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126095641 | 12609564 | 1 | I | 201605 | 20160728 | 20160801 | 20160801 | PER | US-ELI_LILLY_AND_COMPANY-US201607013885 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126095641 | 12609564 | 1 | PS | FORTEO | TERIPARATIDE | 1 | Unknown | UNK, QD | Y | U | C471303D | 21318 | INJECTION | QD | |||||
| 126095641 | 12609564 | 2 | C | NEURONTIN | GABAPENTIN | 1 | U | 0 | |||||||||||
| 126095641 | 12609564 | 3 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126095641 | 12609564 | 4 | C | VITAMIN D /07503901/ | 2 | U | 0 | ||||||||||||
| 126095641 | 12609564 | 5 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | UNK, PRN | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126095641 | 12609564 | 1 | Osteoporosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126095641 | 12609564 | Musculoskeletal pain | |
| 126095641 | 12609564 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126095641 | 12609564 | 1 | 20160401 | 20160715 | 0 |